Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
16,411,002
-
Shares change
-
+617,701
-
Total reported value, excl. options
-
$332,653,845
-
Value change
-
+$21,575,010
-
Put/Call ratio
-
30.6%
-
Number of buys
-
48
-
Number of sells
-
-42
-
Price
-
$20.27
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q4 2015
105 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q4 2015.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,411,002 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,865,647 shares), FMR LLC (1,896,454 shares), JPMORGAN CHASE & CO (1,821,287 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,173,486 shares), FRANKLIN RESOURCES INC (686,500 shares), VANGUARD GROUP INC (655,682 shares), BlackRock Fund Advisors (535,292 shares), MILLENNIUM MANAGEMENT LLC (429,188 shares), MORGAN STANLEY (426,861 shares), and PERCEPTIVE ADVISORS LLC (421,188 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.